1. Home
  2. PHVS vs AVNS Comparison

PHVS vs AVNS Comparison

Compare PHVS & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • AVNS
  • Stock Information
  • Founded
  • PHVS 2015
  • AVNS 2014
  • Country
  • PHVS Netherlands
  • AVNS United States
  • Employees
  • PHVS N/A
  • AVNS N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • AVNS Industrial Specialties
  • Sector
  • PHVS Health Care
  • AVNS Health Care
  • Exchange
  • PHVS Nasdaq
  • AVNS Nasdaq
  • Market Cap
  • PHVS 1.0B
  • AVNS 1.1B
  • IPO Year
  • PHVS 2021
  • AVNS N/A
  • Fundamental
  • Price
  • PHVS $24.15
  • AVNS $18.70
  • Analyst Decision
  • PHVS Buy
  • AVNS Hold
  • Analyst Count
  • PHVS 6
  • AVNS 1
  • Target Price
  • PHVS $35.67
  • AVNS N/A
  • AVG Volume (30 Days)
  • PHVS 97.2K
  • AVNS 199.3K
  • Earning Date
  • PHVS 11-08-2024
  • AVNS 10-30-2024
  • Dividend Yield
  • PHVS N/A
  • AVNS N/A
  • EPS Growth
  • PHVS N/A
  • AVNS N/A
  • EPS
  • PHVS N/A
  • AVNS 0.34
  • Revenue
  • PHVS N/A
  • AVNS $681,500,000.00
  • Revenue This Year
  • PHVS N/A
  • AVNS $5.32
  • Revenue Next Year
  • PHVS N/A
  • AVNS $4.98
  • P/E Ratio
  • PHVS N/A
  • AVNS $39.73
  • Revenue Growth
  • PHVS N/A
  • AVNS N/A
  • 52 Week Low
  • PHVS $15.00
  • AVNS $17.39
  • 52 Week High
  • PHVS $33.00
  • AVNS $25.36
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 68.12
  • AVNS 21.50
  • Support Level
  • PHVS $21.26
  • AVNS $18.01
  • Resistance Level
  • PHVS $25.40
  • AVNS $22.86
  • Average True Range (ATR)
  • PHVS 1.22
  • AVNS 0.65
  • MACD
  • PHVS 0.33
  • AVNS -0.44
  • Stochastic Oscillator
  • PHVS 74.57
  • AVNS 12.25

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: